Anhui Palo Alto Pharmaceuticals, Inc.
Clinical trials sponsored by Anhui Palo Alto Pharmaceuticals, Inc., explained in plain language.
-
New asthma inhaler shows promise in early trial
Disease control Recruiting nowThis study tests a new corticosteroid inhaler called PA9159 in 30 adults with asthma. The goal is to see if it safely improves lung function over 4 weeks. Participants will use the inhaler and have their breathing measured. This is a phase 2 trial, meaning it's still early but lo…
Phase: PHASE2 • Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New asthma inhaler shows promise in early trial
Disease control Recruiting nowThis study tests a new inhaled steroid called PA9159 for adults with asthma. The goal is to see if it safely improves lung function over 4 weeks. About 60 participants will use the inhaler and have their breathing measured. This is an early-phase trial to check safety and effecti…
Phase: PHASE2 • Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC